Labs are Vital(TM) Program Targets Science-Minded Students Through Facebook Social Media Network

AbbottIn an effort to attract young people to the clinical laboratory profession, Labs Are Vital(TM), an initiative sponsored by Abbott, has tapped into Facebook, a popular social networking Web site, to reach out to more than four million students with an interest in life sciences.

A Facebook page, sponsored by Labs Are Vital, will enable interested, career-minded high school and college students to meet clinical lab science students or recent graduates and learn about the benefits and challenges of the profession from their peers.

Recruitment is one of many goals of the Labs Are Vital program. Others include improving the visibility of the clinical lab and demonstrating the value of the lab to the greater healthcare community.

Abbott (NYSE: ABT) has been joined by many of the most influential and professional organizations in the clinical lab, who share these goals, including: Clinical Laboratory Management Association (CLMA), American Society for Clinical Laboratory Science (ASCLS), American Society for Clinical Pathology (ASCP), American Medical Technologists (AMT), American Association of Bioanalysts (AAB), American Association for Clinical Chemistry (AACC), Association of Public Health Laboratories (APHL), and AABB,.

According to statistics compiled by ASCP, there currently may be as many as 40,000 unfilled clinical laboratory jobs in the United States. The shortage of clinical lab scientists is a serious problem, and the stakes are high. According to U.S. Department of Labor projections, approximately 13,800 medical laboratory professionals will be needed every year through 2012 to fill vacant positions. Unfortunately, fewer than 5,000 professionals are graduating from educational programs each year.

Clinical laboratory professionals play a leading role in monitoring health, diagnosing diseases, and assessing the treatment of patients. More than 70 percent of the objective information used to make diagnostic decisions is derived from the clinical lab. This tremendous contribution comes at a great value: most clinical labs take up less than 5 percent of a hospital's operating budget.

Online Scholarship Contest and Other Recruitment Programs:
As part of the Facebook initiative, the Labs Are Vital collaboration is also offering an online scholarship contest for college and high school students. Abbott is joined in this effort by ASCLS, APHL, and Blood Systems, Inc.

Contest entrants must submit a video, advertisement, or T-shirt design that encourages others to consider careers in laboratory medicine. Submissions selected for the semi-finalist category will be available to view online where Facebook members will vote on those that most creatively illustrate why clinical lab science is cutting-edge and how laboratorians make a difference.

Other recruitment activities include the launch of a student-focused Web site, http://www.LabScienceCareers.com, where students can find information on career opportunities and educational programs in clinical lab sciences.

Clinical Lab Careers Video

About Labs Are Vital(TM)
Labs Are Vital is a multi-pronged, multi-year education and awareness program sponsored by Abbott that is designed to highlight the critical role that laboratory professionals play in healthcare and to address the issues facing laboratories today. The program - which includes a public awareness campaign, an Instrument Donation Program, and a variety of Web-based resources for laboratory professionals - focuses attention on the life-saving work clinical laboratory scientists provide in diagnosing disease and improving health outcomes.

Most Popular Now

Pfizer and BioNTech complete submission to Europea…

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced they have completed a submission to the European Medicines Agency (EMA) for an Omicron-adapted biva...

AstraZeneca to acquire TeneoTwo and its clinical-s…

AstraZeneca announced an agreement to acquire TeneoTwo, Inc. (TeneoTwo)i, including its Phase I clinical-stage CD19/CD3 T-cell engager, TNB-486, currently under evaluatio...

Lilly will supply an additional 150,000 doses of b…

Eli Lilly and Company (NYSE: LLY) announced a modified purchase agreement with the U.S. government to supply an additional 150,000 doses of bebtelovimab for approximately...

Bayer to sell men's health product Nebido™ to Grün…

Bayer and Grünenthal have entered into a definitive agreement regarding the sale of Bayer's men's health product Nebido™ (testosterone undecanoate), for a purchase price ...

Demonstration of a potent, universal coronavirus m…

The SARS-CoV-2 that causes COVID-19 has killed 6.3 million people worldwide since 2019, painfully highlighting the vulnerability of humanity to novel coronaviruses. Re...

Vaccine protection against COVID-19 short-lived, b…

Since COVID-19 vaccines first became available to protect against infection and severe illness, there has been much uncertainty about how long the protection lasts, and w...

SARS-CoV-2 hijacks nanotubes between neurons to in…

COVID-19 often leads to neurological symptoms, such as a loss of taste or smell, or cognitive impairments (including memory loss and concentration difficulties), both dur...

Anti-inflammatory compound shows potential in trea…

An anti-inflammatory compound may have the potential to treat systemic inflammation and brain injury in patients with severe COVID-19 and significantly reduce their chanc...

Pfizer and BioNTech advance COVID-19 vaccine strat…

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the companies have initiated a randomized, active-controlled, observer-blind, Phase 2 study to...

Vaccine-induced immune response to omicron wanes s…

Although COVID-19 booster vaccinations in adults elicit high levels of neutralizing antibodies against the Omicron variant of SARS-CoV-2, antibody levels decrease substan...

Scientists develop new biomimetic formulation for …

Glioblastoma multiforme (GBM) is an aggressive brain cancer with a poor prognosis and few treatment options. New and effective approaches for GBM treatment are therefore ...

New needle-free nasal vaccine shows promise for CO…

New research shows that a needle-free mucosal bacteriophage (phage) T4-based COVID-19 vaccine is effective against SARS-CoV-2 infection. The findings were published in mB...